Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Gains from Investment Securities (2017 - 2025)

Eton Pharmaceuticals' Gains from Investment Securities history spans 8 years, with the latest figure at -$1167.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 100.54% to -$1167.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $217833.0, a 0.53% decrease, with the full-year FY2025 number at $5.9 million, changed 0.12% from a year prior.
  • Gains from Investment Securities hit -$1167.0 in Q4 2025 for Eton Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ETON hit a ceiling of $6.3 million in Q2 2024 and a floor of -$1167.0 in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $2.1 million across 5 years, with a median of $837698.0 in 2022.
  • The widest YoY moves for Gains from Investment Securities: up 302057.85% in 2025, down 100.54% in 2025.
  • Tracing ETON's Gains from Investment Securities over 5 years: stood at $3.6 million in 2021, then tumbled by 64.46% to $1.3 million in 2022, then plummeted by 95.99% to $50867.0 in 2023, then surged by 326.6% to $217000.0 in 2024, then plummeted by 100.54% to -$1167.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ETON at -$1167.0 in Q4 2025, $6.0 million in Q3 2025, and $6.0 million in Q2 2025.